A detailed history of Glenmede Trust CO Na transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 17,498 shares of CDMO stock, worth $208,751. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,498
Previous 12,686 37.93%
Holding current value
$208,751
Previous $90,000 121.11%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$6.7 - $12.45 $32,240 - $59,909
4,812 Added 37.93%
17,498 $199,000
Q2 2024

Aug 14, 2024

BUY
$6.34 - $9.28 $10,917 - $15,980
1,722 Added 15.71%
12,686 $90,000
Q1 2024

May 15, 2024

BUY
$5.86 - $8.79 $64,249 - $96,373
10,964 New
10,964 $73,000
Q4 2020

Feb 16, 2021

SELL
$7.25 - $11.76 $717 - $1,164
-99 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$6.53 - $8.6 $646 - $851
99 New
99 $0

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $742M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.